(19)

(11)

EP 3 893 949 A1

(12)

(43) Date of publication: 20.10.2021 Bulletin 2021/42 (21) Application number: 18943193.5 (22) Date of filing: 13.12.2018

(51) International Patent Classification (IPC):  A61L 27/36(2006.01) C12M 1/00(2006.01) C12M 1/36(2006.01) C12M 1/12(2006.01) C12M 1/33(2006.01) C12M 1/34(2006.01) C12M 1/26(2006.01) (52) Cooperative Patent Classification (CPC): C12M 45/09 (86) International application number: PCT/US2018/065405 (87) International publication number: WO 2020/122916 (18.06.2020 Gazette 2020/25)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: KH MA MD TN (71) Applicant: Koligo Therapeutics, Inc. New Albany, Indiana 47150 (US)	(72) Inventors: WOLTERS, Rolf Houston, Texas 77046 (US) VALENTI, Jules Houston, Texas 77046 (US) GURSKI, Tom Houston, Texas 77046 (US) (74) Representative: Pearl Cohen Zedek Latzer Baratz UK LLP  The Gridiron Building One Pancras Square London N1C 4AG London N1C 4AG (GB)